1-3 of 3
Jennifer Roth
Close
Sort by
Journal Articles

Heterogeneity of Molecular Mechanisms Determining Blood Cancer Cell Lines Resistance to Natural Killer Cells in the Context of Tumor-Stromal Interactions: Insights from Studies of Pooled "DNA-Barcoded" Cell Line Panels

Sara Gandolfi, MD, Michal Sheffer, PhD, Olli Dufva, Khalid Saeed, Emily Lowry, Olga Dashevsky, PhD, Ryosuke Shirasaki, MD PhD, Ricardo De Matos Simoes, PhD, Jennifer Roth, Rizwan Romee, MD PhD, Satu Mustjoki, MD PhD, Constantine S. Mitsiades, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 620.
https://doi.org/10.1182/blood-2019-130793
Published: 2019
Journal Articles

Pharmacological Perturbation of the Immunoproteasome in Hematologic Neoplasias: Therapeutic Implications

Sondra L. Downey-Kopyscinski, PhD, Ricardo De Matos Simoes, PhD, Megan Bariteau, BSc, Minasri L. Borah, Sam Bender, Janaka Foneska, Jennifer Roth, Richard Groen, Gina Walter, Manja Friese-Hamim, Samantha M. Goodstal, Michael Sanderson, Constantine S. Mitsiades, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1291.
https://doi.org/10.1182/blood-2019-130356
Published: 2019
Journal Articles

Identification and Validation of Molecular Markers of Tumor Cell Resistance to Natural Killer Cells through CRISPR-Based Screens and Large-Scale Phenotypic Screens of Pooled Tumor Cell Lines

Michal Sheffer, PhD, Lotte Wieten, PhD, Channing Yu, MD PhD, Yiguo Yu, PhD, Olga Dashevsky, PhD, Emily Lowry, Jennifer Roth, Aviad Tsherniak, PhD, Chris C Mader, Sam Bender, Jordan Bryan, Cong Zhu, Li Wang, Ricardo De Matos Simoes, PhD, Sara Gandolfi, MD, Eugen Dhimolea, PhD, Megan Bariteau, Todd R. Golub, MD, Constantine S. Mitsiades, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 623.
https://doi.org/10.1182/blood.V130.Suppl_1.623.623
Published: 2017